Protara Therapeutics (NASDAQ:TARA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.

Open	$2.61
Close	$2.69
Volume / Avg.	211.43K / 178.48K
Day Range	$2.60 - $2.78
52 Wk Range	1.04 - 5.24
Market Cap	$51.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	75
Short Interest	17.65%
Days to Cover	10.71

Recent News

Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity

Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, and future plans. Stay updated on Protara Therapeutics' advancements in cancer therapy and FDA alignment for Choline Chloride.

Vandana Singh

Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.61
Close	$2.69
Volume / Avg.	211.43K / 178.48K
Day Range	$2.60 - $2.78
52 Wk Range	1.04 - 5.24
Market Cap	$51.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	75
Short Interest	17.65%
Days to Cover	10.71

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Protara Therapeutics (TARA) stock?

You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.

View our list of the best stock brokerages

Who are Protara Therapeutics (TARA) competitors?

Other companies in Protara Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).

What is the forecast, or price target, for Protara Therapeutics (TARA) stock?

Protara Therapeutics has a consensus price target of $23.33.

What is the current price for Protara Therapeutics (TARA)?

The stock price for Protara Therapeutics (NASDAQ: TARA) is $2.51 last updated November 12, 2024 at 7:41 PM EST.

Does Protara Therapeutics (TARA) pay a dividend?

There are no upcoming dividends for Protara Therapeutics.

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

Protara Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Protara Therapeutics (TARA) going to split?

There is no upcoming split for Protara Therapeutics.

What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Protara Therapeutics

Protara Therapeutics (TARA) Forecast